Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Ubiquitin mediated proteolysis (mmu04120)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
3110006E
14Rik
KLA  ATP  ATP+KLA
 XM_127466 gb|PREDICTED: Mus musculus RIKEN cDNA 3110006E14 gene (3110006E14Rik), mRNA [XM_127466] KLA 1.01 .98 1.01 .95 .99 1.00 .98
ATP .97 .97 1.01 1.04 .99 1.02 .98
KLA/ATP 1.00 1.07 1.04 1.00 .98 1.05 1.00
Aire
KLA  ATP  ATP+KLA
 NM_009646 autoimmune regulator (autoimmune polyendocrinopathy candidiasis ectodermal dystrophy) (Aire), mRNA [NM_009646] KLA 1.03 1.10 1.10 1.04 1.06 .97 .94
ATP 1.07 1.01 1.03 1.01 .95 .95 1.01
KLA/ATP .97 1.09 1.10 .94 .98 .93 .97
AK033698
KLA  ATP  ATP+KLA
 AK033698 adult male cecum cDNA, RIKEN full-length enriched library, clone:9130225F20 product:unclassifiable, full insert sequence. [AK033698] KLA .72 .76 .68 .65 .66 .64 .60
ATP 1.10 1.25 1.41 5.92 4.60 1.14 1.19
KLA/ATP .85 .83 .82 2.24 2.21 1.27 .97
AK039099
KLA  ATP  ATP+KLA
 AK039099 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230095P17 product:hypothetical protein, full insert sequence. [AK039099] KLA .98 1.03 1.03 .97 1.03 .98 .98
ATP .97 .98 1.06 1.01 1.06 1.05 1.04
KLA/ATP .99 .93 .97 .98 1.03 1.00 1.05
AK041861
KLA  ATP  ATP+KLA
 AK041861 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630042J09 product:unclassifiable, full insert sequence [AK041861] KLA .82 .69 .62 .86 .67 .71 .83
ATP .94 .85 1.15 1.08 1.18 .94 .63
KLA/ATP .64 .63 .95 .88 1.07 1.05 .82
Anapc1
KLA  ATP  ATP+KLA
 AK090134 nullipotent stem cell CRL-2070 NE cDNA, RIKEN full-length enriched library, clone:G431003J08 product:meiotic check point regulator, full insert sequence [AK090134] KLA .79 .76 .72 .64 .56 .54 .76
ATP .99 1.04 1.11 .77 .48 .31 .39
KLA/ATP .72 .75 .73 .57 .42 .30 .25
Anapc1
KLA  ATP  ATP+KLA
 NM_008569 anaphase promoting complex subunit 1 (Anapc1), mRNA [NM_008569] KLA 1.00 .89 .81 .89 .66 .75 .74
ATP .88 .79 .97 .46 .48 .93 .76
KLA/ATP .76 .77 .83 .37 .44 .74 .62
Anapc10
KLA  ATP  ATP+KLA
 NM_026904 anaphase promoting complex subunit 10 (Anapc10), mRNA [NM_026904] KLA 1.38 1.24 1.22 1.30 1.13 1.14 1.05
ATP .96 .99 1.22 1.01 .77 1.16 .94
KLA/ATP 1.19 1.24 1.50 1.23 .97 1.17 1.02
Anapc11
KLA  ATP  ATP+KLA
 NM_001038230 anaphase promoting complex subunit 11 homolog (yeast) (Anapc11), transcript variant 1, mRNA [NM_001038230] KLA .89 .90 .91 .85 .82 .78 .82
ATP 1.01 1.06 1.04 1.06 1.00 .85 .75
KLA/ATP .96 .93 .83 .96 .87 .79 .64
Anapc13
KLA  ATP  ATP+KLA
 NM_181394 anaphase promoting complex subunit 13 (Anapc13), mRNA [NM_181394] KLA .98 .96 .89 .99 .85 .91 .72
ATP .99 .95 1.22 1.25 1.23 1.07 .67
KLA/ATP .95 1.01 1.27 1.23 1.35 1.19 .76
Anapc2
KLA  ATP  ATP+KLA
 NM_175300 anaphase promoting complex subunit 2 (Anapc2), mRNA [NM_175300] KLA .90 .92 1.02 .91 1.03 .94 .81
ATP 1.08 1.16 .96 1.18 .86 .75 .94
KLA/ATP 1.04 1.07 .93 1.11 .84 .66 .89
Anapc4
KLA  ATP  ATP+KLA
 NM_024213 anaphase promoting complex subunit 4 (Anapc4), mRNA [NM_024213] KLA .94 .99 1.01 1.08 1.21 1.22 1.09
ATP .95 .91 .86 .69 .61 .89 .96
KLA/ATP .93 .95 .84 .77 .80 .96 1.00
Anapc5
KLA  ATP  ATP+KLA
 NM_021505 anaphase-promoting complex subunit 5 (Anapc5), transcript variant 1, mRNA [NM_021505] KLA .80 .82 .83 .82 .79 .84 1.10
ATP .99 .99 .89 .81 .79 .70 .71
KLA/ATP .82 .81 .72 .62 .63 .73 .68
Anapc7
KLA  ATP  ATP+KLA
 AK049968 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630034H22 product:anaphase-promoting complex subunit 7, full insert sequence. [AK049968] KLA .89 .86 .88 .85 .91 .95 .89
ATP .92 .89 .89 .86 .96 .99 1.00
KLA/ATP .89 .79 .83 .85 .93 .92 .87
Anapc7
KLA  ATP  ATP+KLA
 NM_019805 anaphase promoting complex subunit 7 (Anapc7), mRNA [NM_019805] KLA .65 .69 .70 .79 .91 1.00 .92
ATP .96 .99 .81 .89 1.46 1.30 1.00
KLA/ATP .70 .73 .64 .72 1.14 1.28 1.04
Birc2
KLA  ATP  ATP+KLA
 NM_007465 baculoviral IAP repeat-containing 2 (Birc2), mRNA [NM_007465] KLA 4.63 4.59 3.77 2.79 2.32 2.07 1.84
ATP .95 .88 .84 .92 .76 1.34 1.28
KLA/ATP 4.70 4.93 4.13 2.60 1.34 1.60 2.31
Birc3
KLA  ATP  ATP+KLA
 BC011338 baculoviral IAP repeat-containing 3, mRNA (cDNA clone MGC:18386 IMAGE:3661563), complete cds [BC011338] KLA 5.48 5.46 4.94 4.16 4.91 3.36 3.74
ATP 1.05 1.08 4.21 4.28 2.59 2.55 1.57
KLA/ATP 6.78 8.91 11.01 4.87 2.28 2.12 3.66
Birc3
KLA  ATP  ATP+KLA
 NM_007464 baculoviral IAP repeat-containing 3 (Birc3), mRNA [NM_007464] KLA 17.83 15.88 13.48 11.14 11.79 6.90 6.10
ATP 1.14 1.16 1.70 4.07 5.00 6.33 2.41
KLA/ATP 14.77 16.44 19.09 13.91 8.27 6.22 7.73
Birc6
KLA  ATP  ATP+KLA
 NM_007566 baculoviral IAP repeat-containing 6 (Birc6), mRNA [NM_007566] KLA 1.89 1.67 2.01 2.17 2.66 3.06 2.06
ATP 1.11 1.00 1.45 1.09 1.09 1.66 1.02
KLA/ATP 1.71 1.69 2.18 1.90 1.99 2.82 4.06
Birc7
KLA  ATP  ATP+KLA
 AK053463 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130019N06 product:weakly similar to BA261N11.1.3 (BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7 (LIVIN), ISOFORM 3) (FRAGMENT) [Homo sapiens], full insert sequence [AK05 KLA 1.02 1.02 .93 1.01 .91 1.27 1.07
ATP 1.02 1.03 .99 .93 .96 .98 1.01
KLA/ATP 1.00 1.04 .97 .94 .91 .93 .92
Brca1
KLA  ATP  ATP+KLA
 NM_009764 breast cancer 1 (Brca1), mRNA [NM_009764] KLA .40 .41 .40 .41 .38 .50 .40
ATP 1.13 1.18 1.07 .94 .76 .45 .44
KLA/ATP .42 .38 .41 .47 .50 .68 .46
Btrc
KLA  ATP  ATP+KLA
 NM_009771 beta-transducin repeat containing protein (Btrc), transcript variant 2, mRNA [NM_009771] KLA 1.30 1.33 1.62 1.50 1.93 1.79 1.60
ATP 1.07 1.30 1.05 1.26 .67 .99 1.56
KLA/ATP 1.40 1.61 1.13 1.72 .88 1.50 1.97
Cbl
KLA  ATP  ATP+KLA
 NM_007619 Casitas B-lineage lymphoma (Cbl), mRNA [NM_007619] KLA 1.23 1.22 1.54 1.84 2.25 2.58 2.75
ATP 1.04 1.12 1.07 1.53 1.55 2.12 3.23
KLA/ATP 1.23 1.20 1.22 1.44 1.31 1.88 6.28
Cblb
KLA  ATP  ATP+KLA
 AK045005 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130018P07 product:hypothetical protein, full insert sequence. [AK045005] KLA 1.16 1.11 1.15 1.10 1.16 .98 .93
ATP 1.16 1.23 .98 1.28 1.34 .73 1.55
KLA/ATP 1.26 1.60 1.64 1.23 1.01 .91 1.05
Cblb
KLA  ATP  ATP+KLA
 AK084162 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230004I05 product:unclassifiable, full insert sequence. [AK084162] KLA .97 .98 1.02 1.01 .84 1.02 1.03
ATP 1.03 1.02 .98 1.09 1.05 .96 .96
KLA/ATP 1.07 .95 .91 .98 .98 1.01 1.00
Cblc
KLA  ATP  ATP+KLA
 NM_023224 Casitas B-lineage lymphoma c (Cblc), mRNA [NM_023224] KLA 1.02 .98 1.01 1.02 1.00 .99 1.05
ATP .94 .95 .97 1.04 .99 .97 .99
KLA/ATP 1.00 1.01 .96 .97 .94 .92 .99
Cdc16
KLA  ATP  ATP+KLA
 AK012511 11 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2700071J12 product:unclassifiable, full insert sequence. [AK012511] KLA .97 .92 .89 .90 .93 .92 .99
ATP .97 .94 .89 .92 .89 .94 .91
KLA/ATP .98 .88 .99 .93 .80 .89 .82
Cdc16
KLA  ATP  ATP+KLA
 NM_027276 CDC16 cell division cycle 16 homolog (S. cerevisiae) (Cdc16), mRNA [NM_027276] KLA .96 .98 .97 .90 .89 .85 .88
ATP 1.03 1.02 1.06 .82 .70 .87 .71
KLA/ATP .96 .93 .96 .79 .68 .73 .61
Cdc20
KLA  ATP  ATP+KLA
 NM_023223 cell division cycle 20 homolog (S. cerevisiae) (Cdc20), mRNA [NM_023223] KLA .18 .15 .14 .12 .10 .09 .06
ATP .91 .88 1.33 1.11 .72 .46 .07
KLA/ATP .16 .15 .20 .18 .19 .17 .07
Cdc23
KLA  ATP  ATP+KLA
 NM_178347 CDC23 (cell division cycle 23, yeast, homolog) (Cdc23), mRNA [NM_178347] KLA .74 .76 .75 .74 .72 .79 .79
ATP 1.06 1.04 .91 .71 .48 .60 .71
KLA/ATP .76 .77 .73 .66 .46 .51 .59
Cdc26
KLA  ATP  ATP+KLA
 AK041840 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630041F01 product:unclassifiable, full insert sequence. [AK041840] KLA .92 .88 .95 .88 1.08 .99 1.15
ATP .72 .64 .61 .75 .91 .85 1.04
KLA/ATP .84 .75 .66 .87 .94 .95 .99
Cdc26
KLA  ATP  ATP+KLA
 NM_139291 cell division cycle 26 (Cdc26), mRNA [NM_139291] KLA 1.04 1.07 1.01 1.25 1.38 1.55 1.25
ATP .98 .97 1.06 .91 .91 1.47 1.38
KLA/ATP .88 1.02 1.24 .99 1.25 1.66 1.74
Cdc27
KLA  ATP  ATP+KLA
 NM_145436 cell division cycle 27 homolog (S. cerevisiae) (Cdc27), mRNA [NM_145436] KLA 1.36 1.25 1.22 1.07 1.05 1.06 1.00
ATP .90 .97 1.06 .84 .81 .88 .73
KLA/ATP 1.25 1.22 1.07 .87 .98 .95 .72
Cdc34
KLA  ATP  ATP+KLA
 AK136078 in vitro fertilized eggs cDNA, RIKEN full-length enriched library, clone:7420453J03 product:Similar to cell division cycle 34 homolog [Mus musculus], full insert sequence. [AK136078] KLA 1.11 1.15 1.14 1.23 1.24 1.41 1.56
ATP .94 .99 1.03 1.18 1.56 2.11 1.79
KLA/ATP 1.13 1.15 1.29 1.31 1.64 1.96 2.18
Cdc34
KLA  ATP  ATP+KLA
 NM_177613 cell division cycle 34 homolog (S. cerevisiae) (Cdc34), mRNA [NM_177613] KLA 1.14 1.13 1.15 1.15 1.18 1.42 1.52
ATP .93 .97 1.04 1.19 1.49 2.17 1.83
KLA/ATP 1.11 1.12 1.24 1.36 1.56 2.01 2.18
Cul1
KLA  ATP  ATP+KLA
 NM_012042 cullin 1 (Cul1), mRNA [NM_012042] KLA 1.54 1.57 1.59 1.36 1.13 1.06 1.15
ATP 1.02 1.15 1.00 1.02 1.00 1.16 1.10
KLA/ATP 1.54 1.68 1.30 1.46 .98 1.02 1.12
Cul2
KLA  ATP  ATP+KLA
 NM_029402 cullin 2 (Cul2), mRNA [NM_029402] KLA 2.33 2.37 2.43 1.90 1.34 1.10 1.09
ATP .98 .92 .98 .78 .73 .90 .76
KLA/ATP 2.27 2.19 1.86 1.53 1.07 .95 .81
Cul3
KLA  ATP  ATP+KLA
 AF129738 cullin 3 (Cul3) mRNA, complete cds. [AF129738] KLA 1.50 1.53 1.69 1.43 1.25 1.16 1.08
ATP .96 .87 .94 .72 1.43 1.98 1.15
KLA/ATP 1.36 1.27 1.27 1.23 1.71 1.77 1.44
Cul4a
KLA  ATP  ATP+KLA
 NM_146207 cullin 4A (Cul4a), mRNA [NM_146207] KLA 1.11 1.11 1.22 1.09 1.08 .97 1.10
ATP 1.05 1.14 1.06 1.01 .78 .84 1.16
KLA/ATP 1.12 1.24 1.03 1.03 .79 .85 1.06
Cul4b
KLA  ATP  ATP+KLA
 NM_001110142 cullin 4B (Cul4b), transcript variant 2, mRNA [NM_001110142] KLA .81 .79 .80 .88 .82 .84 .82
ATP .95 .95 1.03 .81 .60 .65 .62
KLA/ATP .76 .76 .75 .58 .59 .65 .50
Cul4b
KLA  ATP  ATP+KLA
 NM_028288 cullin 4B (Cul4b), transcript variant 1, mRNA [NM_028288] KLA 1.00 .92 .95 1.13 .95 1.03 .98
ATP .95 .90 1.38 1.28 1.46 2.38 1.49
KLA/ATP .86 .88 1.20 .94 1.47 2.60 1.92
Cul5
KLA  ATP  ATP+KLA
 BC030380 cullin 5, mRNA (cDNA clone IMAGE:5375640), with apparent retained intron [BC030380] KLA 1.15 1.17 1.04 .95 .88 .73 .78
ATP .99 .84 .70 .42 .95 .95 .63
KLA/ATP 1.08 1.07 .83 .46 .91 .96 .35
Cul5
KLA  ATP  ATP+KLA
 NM_027807 cullin 5 (Cul5), mRNA [NM_027807] KLA 1.37 1.31 1.18 1.26 1.18 1.14 1.17
ATP .99 .91 .87 .74 .90 1.42 1.39
KLA/ATP 1.13 1.23 1.11 .95 .95 1.23 1.23
Cul7
KLA  ATP  ATP+KLA
 AK082134 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230011P08 product:hypothetical Mitochondrial energy transfer proteins (carrier protein) containing protein, full insert sequence. [AK082134] KLA .98 .92 .95 1.01 1.01 1.01 1.00
ATP 1.00 1.07 1.05 .98 1.04 1.02 .96
KLA/ATP .99 .91 1.00 .99 1.00 .97 1.08
Cul7
KLA  ATP  ATP+KLA
 NM_025611 cullin 7 (Cul7), mRNA [NM_025611] KLA .93 .88 .89 .93 .94 .98 .86
ATP 1.01 .97 1.03 .96 .89 .95 .92
KLA/ATP .90 .88 .95 .87 .91 .95 .89
Ddb1
KLA  ATP  ATP+KLA
 NM_015735 damage specific DNA binding protein 1 (Ddb1), mRNA [NM_015735] KLA 1.01 1.01 1.01 .83 .75 .62 .68
ATP 1.05 1.21 .88 1.04 1.01 .76 .61
KLA/ATP 1.17 1.09 .77 .91 .58 .54 .45
Ddb2
KLA  ATP  ATP+KLA
 NM_028119 damage specific DNA binding protein 2 (Ddb2), mRNA [NM_028119] KLA .72 .69 .72 .69 .67 .75 .83
ATP 1.21 1.11 1.21 1.05 .61 .49 .87
KLA/ATP .83 .78 .80 .72 .54 .55 .77
Det1
KLA  ATP  ATP+KLA
 NM_029585 de-etiolated homolog 1 (Arabidopsis) (Det1), mRNA [NM_029585] KLA .93 .90 .93 .95 .86 .94 1.13
ATP 1.07 1.04 1.07 .98 .58 .70 1.23
KLA/ATP .94 1.02 .99 .80 .61 .51 .74
Ercc8
KLA  ATP  ATP+KLA
 AK045333 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130065P18 product:unclassifiable, full insert sequence. [AK045333] KLA .77 .73 .64 .65 .80 .85 1.11
ATP .70 .49 .45 .61 .82 1.07 .97
KLA/ATP .57 .42 .47 .56 .68 .76 .59
Ercc8
KLA  ATP  ATP+KLA
 NM_028042 excision repaiross-complementing rodent repair deficiency, complementation group 8 (Ercc8), mRNA [NM_028042] KLA 1.05 .98 .92 .88 .79 .97 1.18
ATP .93 .83 .70 .62 .73 1.12 1.03
KLA/ATP .92 .88 .72 .65 .62 .84 .77
Fancl
KLA  ATP  ATP+KLA
 NM_025923 Fanconi anemia, complementation group L (Fancl), mRNA [NM_025923] KLA .93 .94 1.02 .97 .80 .70 .53
ATP .92 .90 1.40 1.08 .69 .56 .70
KLA/ATP .86 .89 1.32 .96 .85 .53 .43
Fbxo2
KLA  ATP  ATP+KLA
 NM_176848 F-box protein 2 (Fbxo2), mRNA [NM_176848] KLA 1.36 1.39 1.42 1.50 1.44 1.56 1.37
ATP 1.03 1.06 1.23 1.30 1.33 1.32 1.17
KLA/ATP 1.41 1.50 1.80 1.69 1.77 1.57 1.51
Fbxo4
KLA  ATP  ATP+KLA
 AK015995 adult male testis cDNA, RIKEN full-length enriched library, clone:4930539E23 product:unclassifiable, full insert sequence. [AK015995] KLA 1.29 1.23 1.12 1.02 1.05 .96 1.08
ATP 1.15 1.40 .99 1.10 .97 .87 1.08
KLA/ATP 1.41 1.80 1.40 1.25 1.14 .87 1.14
Fbxo4
KLA  ATP  ATP+KLA
 NM_134099 F-box protein 4 (Fbxo4), mRNA [NM_134099] KLA 2.04 2.05 2.29 2.31 1.48 1.20 1.00
ATP .89 .91 1.35 1.25 1.07 .90 .96
KLA/ATP 1.73 2.12 3.39 2.73 2.33 1.44 1.07
Fbxw11
KLA  ATP  ATP+KLA
 AK010033 adult male tongue cDNA, RIKEN full-length enriched library, clone:2310065A07 product:unclassifiable, full insert sequence. [AK010033] KLA 1.30 1.21 1.27 1.21 1.47 1.01 1.13
ATP 1.19 2.03 1.28 .95 1.43 .99 1.04
KLA/ATP 1.43 1.83 1.40 1.10 1.12 1.05 1.05
Fbxw11
KLA  ATP  ATP+KLA
 NM_134015 F-box and WD-40 domain protein 11 (Fbxw11), mRNA [NM_134015] KLA 3.11 2.78 3.05 3.43 2.16 1.58 1.20
ATP 1.03 .94 1.72 1.19 1.38 1.66 1.01
KLA/ATP 2.76 2.70 4.18 2.07 1.91 2.02 1.71
Fbxw7
KLA  ATP  ATP+KLA
 NM_080428 F-box and WD-40 domain protein 7, archipelago homolog (Drosophila) (Fbxw7), mRNA [NM_080428] KLA 1.73 1.70 1.76 1.67 1.24 1.81 1.07
ATP .94 .81 .79 .95 4.45 1.41 1.34
KLA/ATP 1.65 1.46 1.34 1.56 6.47 2.92 1.54
Fbxw8
KLA  ATP  ATP+KLA
 NM_172721 F-box and WD-40 domain protein 8 (Fbxw8), mRNA [NM_172721] KLA .87 .86 .82 .82 .73 .68 .75
ATP .99 1.07 .93 1.16 .76 .50 .45
KLA/ATP .98 .92 .76 .86 .65 .49 .39
Fzr1
KLA  ATP  ATP+KLA
 NM_019757 fizzy/cell division cycle 20 related 1 (Drosophila) (Fzr1), mRNA [NM_019757] KLA 1.08 .98 .95 1.03 1.44 1.33 .97
ATP 1.06 1.19 .93 1.16 1.05 1.21 .94
KLA/ATP 1.02 1.05 .83 1.04 .84 1.21 1.43
Herc1
KLA  ATP  ATP+KLA
 AK035553 adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530065H03 product:hypothetical HECT domain (Ubiquitin-protein ligase) containing protein, full insert sequence. [AK035553] KLA 2.01 1.73 1.32 1.18 1.17 1.09 .98
ATP .95 .94 1.02 .79 .96 .98 .93
KLA/ATP 1.58 1.59 1.44 .92 1.16 1.04 1.36
Herc1
KLA  ATP  ATP+KLA
 AK047003 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930010L06 product:SIMILAR TO HECT (HOMOLOGOUS TO THE E6-AP (UBE3A) CARBOXYL TERMINUS) DOMAIN AND RCC1 (CHC1)-LIKE DOMAIN (RLD) 1 homolog [Mus musculus], full inse KLA .99 .99 .98 1.04 1.02 1.02 1.00
ATP 1.00 .98 1.06 .94 .97 1.00 1.07
KLA/ATP .97 .99 1.11 1.10 1.06 .99 1.05
Herc1
KLA  ATP  ATP+KLA
 AK085186 13 days embryo lung cDNA, RIKEN full-length enriched library, clone:D430050I15 product:hypothetical protein, full insert sequence. [AK085186] KLA 1.04 1.01 1.03 .97 1.01 1.02 .96
ATP .98 .97 .97 1.05 1.01 1.00 .90
KLA/ATP 1.09 1.12 .95 1.04 1.00 1.00 .89
Herc1
KLA  ATP  ATP+KLA
 XM_001477062 gb|PREDICTED: Mus musculus hect (homologous to the E6-AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 (Herc1), mRNA [XM_001477062] KLA 1.95 1.79 1.75 2.04 1.45 1.39 .86
ATP .99 .82 1.13 .99 .98 1.17 .71
KLA/ATP 1.67 1.91 2.89 1.96 1.88 1.81 1.28
Herc2
KLA  ATP  ATP+KLA
 NM_010418 hect (homologous to the E6-AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 2 (Herc2), mRNA [NM_010418] KLA 1.28 1.24 1.19 .99 1.15 1.07 1.08
ATP 1.19 1.29 1.09 1.08 .68 1.22 .91
KLA/ATP 1.39 1.38 1.15 1.10 .72 1.38 1.17
Herc3
KLA  ATP  ATP+KLA
 NM_028705 hect domain and RLD 3 (Herc3), mRNA [NM_028705] KLA .67 .55 .46 .38 .27 .49 .87
ATP .87 .82 .67 .42 .50 .55 .58
KLA/ATP .54 .48 .35 .25 .33 .51 .63
Herc4
KLA  ATP  ATP+KLA
 AK087864 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330032I01 product:unclassifiable, full insert sequence [AK087864] KLA 1.05 1.05 .99 .98 .96 .99 1.04
ATP 1.01 .98 .93 .94 .96 .98 .97
KLA/ATP 1.02 .98 .94 1.00 .94 1.04 .96
Herc4
KLA  ATP  ATP+KLA
 NM_026101 hect domain and RLD 4 (Herc4), mRNA [NM_026101] KLA 1.35 1.27 1.31 1.49 1.38 1.21 1.15
ATP 1.05 .93 .80 .58 .70 1.05 .94
KLA/ATP 1.32 1.19 1.08 .73 .75 1.21 1.03
Huwe1
KLA  ATP  ATP+KLA
 NM_021523 HECT, UBA and WWE domain containing 1 (Huwe1), mRNA [NM_021523] KLA 1.07 1.01 .98 .95 .92 .90 .93
ATP 1.03 1.02 .94 .82 .89 .90 .85
KLA/ATP 1.07 1.05 .97 .78 .78 .76 .78
Itch
KLA  ATP  ATP+KLA
 AK033318 15 days embryo male testis cDNA, RIKEN full-length enriched library, clone:8030492O04 product:unclassifiable, full insert sequence. [AK033318] KLA .94 .82 .94 .88 1.04 .93 .95
ATP 1.15 1.14 .93 .75 1.42 1.04 .99
KLA/ATP .98 .95 .86 .75 1.25 1.01 .96
Itch
KLA  ATP  ATP+KLA
 AK038333 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130096D14 product:similar to TYROSINE-PROTEIN KINASE JAK3 (EC 2.7.1.112) (JANUS KINASE 3) (JAK-3) [Mus musculus], full insert sequence. [AK038333] KLA .97 .89 .88 .89 .97 .87 .94
ATP 1.03 .87 .72 .90 1.16 1.01 .93
KLA/ATP .94 .89 .83 .80 .94 .93 .93
Itch
KLA  ATP  ATP+KLA
 AK220164 mRNA for mKIAA4011 protein [AK220164] KLA 1.08 .99 1.04 1.13 .99 .99 1.06
ATP .95 .92 1.13 .73 .96 1.33 .93
KLA/ATP .94 .97 1.12 .75 1.10 1.40 1.11
Itch
KLA  ATP  ATP+KLA
 NM_008395 itchy, E3 ubiquitin protein ligase (Itch), mRNA [NM_008395] KLA 1.06 1.01 1.13 1.05 1.00 1.08 1.13
ATP 1.02 1.10 .96 1.02 1.07 1.06 1.22
KLA/ATP 1.07 1.00 .93 1.01 .95 1.10 1.29
Keap1
KLA  ATP  ATP+KLA
 NM_016679 kelch-like ECH-associated protein 1 (Keap1), transcript variant 1, mRNA [NM_016679] KLA 2.39 2.74 2.59 2.87 2.73 2.64 1.76
ATP 1.00 .88 .56 .47 .52 1.39 1.17
KLA/ATP 2.64 2.43 1.82 1.70 1.85 2.03 1.88
Klhl13
KLA  ATP  ATP+KLA
 AK045102 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130032L24 product:hypothetical protein, full insert sequence. [AK045102] KLA 1.03 .99 1.00 .95 1.04 1.07 .99
ATP .95 .98 1.00 .95 .98 1.08 1.07
KLA/ATP 1.02 .94 1.02 .98 1.04 .96 1.02
Klhl13
KLA  ATP  ATP+KLA
 AK053073 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930043E11 product:unclassifiable, full insert sequence [AK053073] KLA .97 1.02 .98 1.02 1.03 1.01 .92
ATP 1.01 .99 1.06 1.02 1.01 .97 1.02
KLA/ATP 1.02 1.06 .98 1.00 .97 1.06 .73
Klhl13
KLA  ATP  ATP+KLA
 NM_026167 kelch-like 13 (Drosophila) (Klhl13), mRNA [NM_026167] KLA .98 .98 1.07 1.01 .99 1.10 1.13
ATP 1.02 .95 1.04 1.00 1.01 .95 .93
KLA/ATP 1.02 1.00 .99 1.02 .99 1.09 1.07
Klhl9
KLA  ATP  ATP+KLA
 NM_172871 kelch-like 9 (Drosophila) (Klhl9), mRNA [NM_172871] KLA 1.12 1.14 1.06 1.07 .99 .92 .96
ATP 1.10 1.20 .92 1.10 1.17 1.35 1.32
KLA/ATP 1.16 1.21 .93 1.04 .85 1.11 1.27
LOC10004
6898
KLA  ATP  ATP+KLA
 XM_001478127 ref|PREDICTED: Mus musculus similar to Cell division cycle 34 homolog (S. cerevisiae) (LOC100046898), mRNA [XM_001478127] KLA .71 .72 .78 .85 .71 .80 1.09
ATP .98 .90 1.10 .94 .87 .72 .67
KLA/ATP .78 .69 .80 .77 .80 .82 .66
Map3k1
KLA  ATP  ATP+KLA
 NM_011945 mitogen-activated protein kinase kinase kinase 1 (Map3k1), mRNA [NM_011945] KLA .30 .25 .37 .56 .68 1.07 .85
ATP .88 .86 1.26 1.04 1.07 .77 .78
KLA/ATP .28 .24 .59 .99 1.49 .97 1.24
Mdm2
KLA  ATP  ATP+KLA
 NM_010786 transformed mouse 3T3 cell double minute 2 (Mdm2), mRNA [NM_010786] KLA 1.77 1.59 1.98 1.51 1.77 1.60 1.77
ATP 1.01 1.21 1.36 3.24 5.04 2.08 1.36
KLA/ATP 1.89 1.86 2.93 5.65 5.98 2.78 2.64
Mgrn1
KLA  ATP  ATP+KLA
 NM_029657 mahogunin, ring finger 1 (Mgrn1), mRNA [NM_029657] KLA .77 .68 .64 .71 .75 1.23 1.39
ATP .83 .80 1.00 .83 1.05 .89 1.33
KLA/ATP .65 .67 .68 .60 .88 .95 1.23
Mid1
KLA  ATP  ATP+KLA
 Y14848 mRNA for midline 1 protein. [Y14848] KLA 3.10 2.97 3.85 3.54 3.31 3.13 1.75
ATP 1.12 1.30 2.80 5.94 4.00 2.35 1.90
KLA/ATP 3.26 3.91 6.87 8.98 6.61 5.02 4.37
Mm.12665
KLA  ATP  ATP+KLA
 146134444 Unknown KLA 1.39 1.39 1.68 1.34 1.20 1.08 1.11
ATP .96 .93 .89 .72 1.41 1.77 1.12
KLA/ATP 1.30 1.19 1.16 1.16 1.50 1.66 1.39
Mm.18787
9
KLA  ATP  ATP+KLA
 149250519 Unknown KLA .98 .98 1.02 1.05 1.01 1.10 1.02
ATP 1.03 1.00 .98 1.02 1.02 1.04 .99
KLA/ATP .99 1.07 1.04 1.02 .94 .97 .93
Mm.20929
KLA  ATP  ATP+KLA
 134288897 Unknown KLA 1.19 1.11 .99 .89 .97 1.06 .97
ATP 1.04 1.07 1.13 .89 .59 1.32 .91
KLA/ATP 1.17 1.18 1.27 .95 .75 1.41 1.16
Mm.22176
9
KLA  ATP  ATP+KLA
 120407053 Unknown KLA .88 .86 .83 .87 .76 .64 .70
ATP 1.01 1.00 1.16 1.09 .84 .52 .39
KLA/ATP .91 .93 .97 .83 .74 .46 .32
Mm.26687
1
KLA  ATP  ATP+KLA
 80978931 Unknown KLA .67 .63 .70 .83 1.66 1.43 1.54
ATP 1.20 1.24 1.22 1.26 1.80 .81 1.02
KLA/ATP .63 .56 .83 1.06 1.26 .70 1.34
Mm.27992
3
KLA  ATP  ATP+KLA
 56699422 Unknown KLA .96 .90 .93 .88 .86 .84 .91
ATP .97 1.02 1.03 .99 .91 .89 .90
KLA/ATP .90 .93 .93 .93 .90 .91 .81
Mm.28924
8
KLA  ATP  ATP+KLA
 148747277 Unknown KLA 1.36 1.32 1.33 1.38 1.29 1.32 .98
ATP .86 .92 1.42 1.26 1.10 .95 .57
KLA/ATP 1.16 1.34 1.72 1.53 1.42 .87 .61
Mm.31813
3
KLA  ATP  ATP+KLA
 146198813 Unknown KLA 1.04 1.03 1.00 .96 1.06 .89 .96
ATP 1.03 1.01 .96 1.03 .94 .97 .94
KLA/ATP 1.08 .99 .99 .97 .93 1.00 .96
Mm.33565
9
KLA  ATP  ATP+KLA
 160333365 Unknown KLA 5.54 4.69 3.93 3.03 2.00 1.91 1.69
ATP .98 .81 1.01 .78 .68 1.71 1.10
KLA/ATP 5.05 4.44 5.07 2.38 1.34 1.88 2.00
Mm.35584
KLA  ATP  ATP+KLA
 70909358 Unknown KLA .22 .25 .28 .33 .40 .77 .46
ATP 1.05 .96 1.08 .56 1.10 .79 .74
KLA/ATP .23 .25 .32 .25 .90 1.02 .60
Mm.37167
3
KLA  ATP  ATP+KLA
 85662412 Unknown KLA 1.10 1.15 1.02 1.11 1.26 1.04 1.07
ATP 1.02 1.06 1.17 1.13 1.08 .92 1.10
KLA/ATP 1.04 1.08 1.27 1.14 1.12 1.07 1.11
Mm.44792
6
KLA  ATP  ATP+KLA
 133922595 Unknown KLA 1.21 1.10 1.17 1.20 1.13 1.21 1.19
ATP .95 .93 1.27 .98 1.46 1.14 .98
KLA/ATP 1.14 1.15 1.74 1.52 1.54 1.31 1.15
Mm.46002
4
KLA  ATP  ATP+KLA
 38348245 Unknown KLA 1.22 1.25 1.25 1.19 1.22 1.47 1.14
ATP 1.03 .94 1.01 1.01 2.67 2.31 1.37
KLA/ATP 1.35 1.19 1.27 1.22 1.99 1.83 1.45
Mm.46087
0
KLA  ATP  ATP+KLA
 127139932 Unknown KLA 3.23 3.80 4.13 4.48 3.27 3.77 1.98
ATP .90 1.19 1.74 5.82 5.43 2.61 1.82
KLA/ATP 3.61 4.16 5.19 8.67 7.33 5.97 5.15
Mm.81698
KLA  ATP  ATP+KLA
 158937287 Unknown KLA .95 1.02 1.04 .98 1.01 1.04 1.08
ATP 1.00 1.03 .97 1.00 1.03 .98 .96
KLA/ATP 1.07 1.00 .94 .98 1.03 1.05 .97
Nedd4
KLA  ATP  ATP+KLA
 NM_010890 neural precursor cell expressed, developmentally down-regulated gene 4 (Nedd4), mRNA [NM_010890] KLA 1.00 1.04 1.03 1.02 .85 .94 .95
ATP 1.04 1.05 1.03 1.06 1.01 .89 .80
KLA/ATP 1.04 .99 1.02 1.05 .99 .90 .82
Nedd4l
KLA  ATP  ATP+KLA
 NM_031881 neural precursor cell expressed, developmentally down-regulated gene 4-like (Nedd4l), transcript variant 2, mRNA [NM_031881] KLA 1.42 1.30 1.43 .83 .53 .47 .54
ATP 1.01 1.24 1.06 2.34 8.62 2.38 1.38
KLA/ATP 1.65 1.59 1.17 1.66 3.43 2.75 1.38
Nhlrc1
KLA  ATP  ATP+KLA
 NM_175340 NHL repeat containing 1 (Nhlrc1), mRNA [NM_175340] KLA .21 .21 .21 .22 .25 .39 .68
ATP .87 .78 .81 .43 .28 .50 1.00
KLA/ATP .19 .19 .25 .19 .29 .36 .34
Park2
KLA  ATP  ATP+KLA
 NM_016694 parkin (Park2), mRNA [NM_016694] KLA .95 .95 .94 1.01 .86 .83 .99
ATP .97 .96 1.08 1.03 .85 .70 .74
KLA/ATP .95 .93 1.00 1.01 .86 .69 .77
Pias1
KLA  ATP  ATP+KLA
 NM_019663 protein inhibitor of activated STAT 1 (Pias1), mRNA [NM_019663] KLA 1.60 1.58 1.85 1.69 1.49 1.22 1.00
ATP 1.09 1.10 .93 .86 .96 .68 .88
KLA/ATP 1.64 1.41 1.29 1.32 1.37 1.01 1.26
Pias2
KLA  ATP  ATP+KLA
 NM_008602 protein inhibitor of activated STAT 2 (Pias2), mRNA [NM_008602] KLA .85 .84 .82 .87 .80 1.05 1.03
ATP .88 .95 1.02 .86 .93 1.17 1.16
KLA/ATP .76 .83 .91 .77 .93 1.15 1.16
Pias3
KLA  ATP  ATP+KLA
 NM_018812 protein inhibitor of activated STAT 3 (Pias3), transcript variant 2, mRNA [NM_018812] KLA .91 .88 .88 .80 .78 .94 .99
ATP 1.07 1.25 .89 .96 .60 .68 .83
KLA/ATP 1.00 .89 .76 .79 .62 .71 .93
Pias3
KLA  ATP  ATP+KLA
 NM_146135 protein inhibitor of activated STAT 3 (Pias3), transcript variant 1, mRNA [NM_146135] KLA .70 .67 .70 .62 .79 1.00 .86
ATP 1.07 1.13 .88 .77 .50 .66 .80
KLA/ATP .81 .71 .69 .67 .64 .60 1.06
Pias4
KLA  ATP  ATP+KLA
 NM_021501 protein inhibitor of activated STAT 4 (Pias4), mRNA [NM_021501] KLA .97 1.13 1.26 1.38 1.87 1.63 1.62
ATP 1.12 1.30 .89 1.24 1.93 1.64 1.92
KLA/ATP 1.33 1.11 .74 1.30 1.61 2.07 2.69
Pml
KLA  ATP  ATP+KLA
 NM_008884 promyelocytic leukemia (Pml), transcript variant 1, mRNA [NM_008884] KLA 5.73 6.01 7.28 6.76 5.85 5.36 2.28
ATP 1.07 1.10 .92 .89 .97 3.78 2.67
KLA/ATP 6.48 6.51 6.81 8.78 6.61 7.57 6.55
Ppil2
KLA  ATP  ATP+KLA
 NM_144954 peptidylprolyl isomerase (cyclophilin)-like 2 (Ppil2), mRNA [NM_144954] KLA .94 .96 .96 .96 1.03 1.17 1.10
ATP .99 1.01 1.00 .94 .61 .78 1.14
KLA/ATP .93 .99 .97 .93 .71 .80 1.35
Prpf19
KLA  ATP  ATP+KLA
 NM_134129 PRP19/PSO4 pre-mRNA processing factor 19 homolog (S. cerevisiae) (Prpf19), mRNA [NM_134129] KLA .85 .99 .95 .81 .66 .70 .75
ATP 1.01 1.19 .67 .75 .58 .58 .52
KLA/ATP 1.03 1.10 .77 .74 .53 .43 .42
Rbx1
KLA  ATP  ATP+KLA
 NM_019712 ring-box 1 (Rbx1), mRNA [NM_019712] KLA 1.04 1.01 .98 1.09 1.06 1.14 1.09
ATP .92 .89 1.13 1.16 1.68 1.07 .83
KLA/ATP .99 .99 1.25 1.31 2.63 2.06 .67
Rchy1
KLA  ATP  ATP+KLA
 NM_026557 ring finger and CHY zinc finger domain containing 1 (Rchy1), mRNA [NM_026557] KLA .51 .57 .70 1.01 1.04 .77 .66
ATP .97 .91 .91 .94 .99 .76 1.05
KLA/ATP .48 .50 .61 .62 .85 .97 .97
Rfwd2
KLA  ATP  ATP+KLA
 AK042587 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730008F16 product:unclassifiable, full insert sequence. [AK042587] KLA 1.35 1.38 1.24 1.23 1.04 1.07 1.08
ATP .94 .84 .97 .89 .86 .88 .84
KLA/ATP 1.21 1.27 1.23 1.04 .99 .90 .89
Rfwd2
KLA  ATP  ATP+KLA
 NM_011931 ring finger and WD repeat domain 2 (Rfwd2), mRNA [NM_011931] KLA 3.14 3.10 3.09 3.13 2.22 1.83 1.59
ATP .99 .88 1.00 .71 .71 1.15 .87
KLA/ATP 2.95 2.99 3.16 1.81 1.26 .97 1.17
Rhobtb1
KLA  ATP  ATP+KLA
 NM_001081347 Rho-related BTB domain containing 1 (Rhobtb1), mRNA [NM_001081347] KLA .25 .27 .33 .62 .68 .77 .37
ATP .89 .73 .83 .45 .30 .62 .52
KLA/ATP .23 .22 .34 .29 .34 .48 .47
Rhobtb2
KLA  ATP  ATP+KLA
 AK021405 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130206H14 product:inferred: Mus musculus DBC2 protein (Dbc2) mRNA, complete cds, full insert sequence [AK021405] KLA 1.06 1.01 .97 .98 .98 .99 1.08
ATP .96 .96 .94 .93 .96 .97 .96
KLA/ATP 1.06 .97 1.02 1.00 .96 1.00 .96
Rhobtb2
KLA  ATP  ATP+KLA
 AK122354 mRNA for mKIAA0717 protein [AK122354] KLA .93 1.02 .97 1.07 .92 .98 1.04
ATP .97 .94 1.00 .99 .96 .97 .97
KLA/ATP 1.01 1.10 .89 1.01 1.02 .99 .78
Rhobtb2
KLA  ATP  ATP+KLA
 NM_153514 Rho-related BTB domain containing 2 (Rhobtb2), mRNA [NM_153514] KLA .90 .91 1.00 .93 .83 .89 1.21
ATP .95 .93 .92 .71 .52 .67 1.01
KLA/ATP .86 .86 .86 .71 .69 .64 .66
Rnf7
KLA  ATP  ATP+KLA
 NM_011279 ring finger protein 7 (Rnf7), mRNA [NM_011279] KLA .88 .85 .80 .80 .76 .82 1.00
ATP .93 .97 1.10 1.01 .85 .76 .67
KLA/ATP .78 .78 .90 .81 .78 .70 .65
Sae1
KLA  ATP  ATP+KLA
 AK087556 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130319M10 product:ubiquitin-like 1 (sentrin) activating enzyme E1A, full insert sequence. [AK087556] KLA .63 .66 .62 .54 .51 .50 .55
ATP .99 1.08 .97 1.07 .82 .56 .56
KLA/ATP .66 .71 .64 .66 .59 .49 .43
Sae1
KLA  ATP  ATP+KLA
 NM_019748 SUMO1 activating enzyme subunit 1 (Sae1), mRNA [NM_019748] KLA .75 .81 .82 .69 .67 .61 .57
ATP .96 1.15 1.06 1.26 .93 .57 .56
KLA/ATP .83 .87 .78 .97 .73 .47 .33
Siah1a
KLA  ATP  ATP+KLA
 NM_009172 seven in absentia 1A (Siah1a), mRNA [NM_009172] KLA 1.09 1.05 1.03 1.00 1.21 1.17 1.29
ATP .95 .99 .82 .77 1.02 .98 .98
KLA/ATP 1.06 1.04 .82 .78 .76 .85 1.06
Siah1b
KLA  ATP  ATP+KLA
 NM_009173 seven in absentia 1B (Siah1b), mRNA [NM_009173] KLA 1.20 1.10 1.09 1.08 1.00 .91 .84
ATP .97 .90 .79 .75 1.46 1.24 .84
KLA/ATP 1.06 1.08 .85 .66 1.21 1.40 1.08
Skp1a
KLA  ATP  ATP+KLA
 NM_011543 S-phase kinase-associated protein 1A (Skp1a), mRNA [NM_011543] KLA 1.05 1.00 .92 .92 .88 .89 1.02
ATP .90 .98 1.21 1.43 1.32 1.46 1.09
KLA/ATP .93 1.01 1.11 1.31 1.21 1.27 1.21
Skp2
KLA  ATP  ATP+KLA
 AF083215 SCF complex protein Skp2 mRNA, complete cds. [AF083215] KLA .36 .37 .34 .37 .44 .78 .60
ATP 1.05 1.35 .85 .66 .83 .54 .76
KLA/ATP .33 .39 .37 .37 .65 .73 .62
Smurf1
KLA  ATP  ATP+KLA
 NM_001038627 SMAD specific E3 ubiquitin protein ligase 1 (Smurf1), transcript variant 1, mRNA [NM_001038627] KLA 1.94 1.84 1.87 1.68 1.85 2.06 2.12
ATP 1.04 1.10 1.05 1.05 1.43 2.14 2.38
KLA/ATP 1.95 2.05 1.81 1.79 1.55 2.17 3.75
Smurf2
KLA  ATP  ATP+KLA
 NM_025481 SMAD specific E3 ubiquitin protein ligase 2 (Smurf2), mRNA [NM_025481] KLA .66 .66 .71 .75 1.11 1.14 1.16
ATP 1.03 1.10 1.22 .90 1.15 1.09 1.19
KLA/ATP .71 .72 .76 .65 1.04 .96 1.30
Socs1
KLA  ATP  ATP+KLA
 NM_009896 suppressor of cytokine signaling 1 (Socs1), mRNA [NM_009896] KLA 27.36 22.16 20.64 23.08 17.74 21.71 10.12
ATP .91 .72 2.03 12.69 9.16 19.87 6.80
KLA/ATP 26.70 24.56 28.15 31.28 26.32 29.95 22.51
Socs3
KLA  ATP  ATP+KLA
 NM_007707 suppressor of cytokine signaling 3 (Socs3), mRNA [NM_007707] KLA 7.56 6.68 6.29 7.36 6.47 7.03 5.33
ATP 1.51 1.75 4.63 6.27 6.92 7.74 4.64
KLA/ATP 6.82 6.77 9.19 8.32 9.51 8.98 8.33
Stub1
KLA  ATP  ATP+KLA
 NM_019719 STIP1 homology and U-Box containing protein 1 (Stub1), mRNA [NM_019719] KLA .73 .76 .75 .67 .76 .72 .86
ATP 1.07 1.15 .86 1.04 .96 .70 .84
KLA/ATP .77 .84 .67 .82 .68 .71 .73
Syvn1
KLA  ATP  ATP+KLA
 NM_028769 synovial apoptosis inhibitor 1, synoviolin (Syvn1), mRNA [NM_028769] KLA 1.33 1.36 1.25 1.15 1.33 1.28 1.39
ATP 1.05 1.08 1.01 .90 .89 1.27 1.19
KLA/ATP 1.35 1.29 1.17 1.08 1.13 1.34 1.40
Tceb1
KLA  ATP  ATP+KLA
 NM_026456 transcription elongation factor B (SIII), polypeptide 1 (Tceb1), mRNA [NM_026456] KLA 1.27 1.21 1.25 1.65 1.46 1.21 1.26
ATP 1.11 1.01 1.44 1.34 1.46 1.17 .74
KLA/ATP 1.20 1.48 2.16 1.77 1.56 1.13 .89
Tceb2
KLA  ATP  ATP+KLA
 NM_026305 transcription elongation factor B (SIII), polypeptide 2 (Tceb2), mRNA [NM_026305] KLA .99 1.00 .96 1.01 1.04 .96 1.24
ATP 1.15 1.17 1.03 1.36 1.25 1.05 1.27
KLA/ATP 1.07 1.13 1.08 1.30 1.21 1.23 1.56
Traf6
KLA  ATP  ATP+KLA
 NM_009424 Tnf receptor-associated factor 6 (Traf6), mRNA [NM_009424] KLA 1.19 1.28 1.34 1.20 1.23 1.23 1.28
ATP 1.06 1.12 .92 1.15 2.46 1.84 1.40
KLA/ATP 1.32 1.37 .89 1.16 1.45 1.49 1.46
Trim32
KLA  ATP  ATP+KLA
 NM_053084 tripartite motif-containing 32 (Trim32), mRNA [NM_053084] KLA .77 .78 .91 .87 .82 .77 .93
ATP .94 .98 .91 .79 .85 .82 1.00
KLA/ATP .80 .77 .72 .69 .86 .89 .83
Trim37
KLA  ATP  ATP+KLA
 NM_197987 tripartite motif-containing 37 (Trim37), mRNA [NM_197987] KLA .75 .73 .68 .59 .48 .45 .58
ATP 1.01 1.05 .95 .83 .64 .52 .51
KLA/ATP .72 .70 .65 .61 .50 .46 .40
Trip12
KLA  ATP  ATP+KLA
 NM_133975 thyroid hormone receptor interactor 12 (Trip12), mRNA [NM_133975] KLA 1.47 1.54 1.60 1.64 1.51 1.45 1.08
ATP 1.01 1.00 1.04 .80 1.04 1.11 .99
KLA/ATP 1.52 1.46 1.54 1.17 1.57 1.55 1.41
Uba1
KLA  ATP  ATP+KLA
 NM_009457 ubiquitin-like modifier activating enzyme 1 (Uba1), mRNA [NM_009457] KLA 1.26 1.34 1.42 1.39 1.58 1.52 1.43
ATP 1.08 1.15 .65 .82 .75 1.01 1.38
KLA/ATP 1.45 1.49 .82 1.13 .70 1.21 2.30
Uba2
KLA  ATP  ATP+KLA
 NM_016682 ubiquitin-like modifier activating enzyme 2 (Uba2), mRNA [NM_016682] KLA .66 .73 .65 .63 .63 .70 .77
ATP .98 1.02 1.04 .97 .73 .59 .67
KLA/ATP .66 .67 .61 .65 .56 .57 .53
Uba3
KLA  ATP  ATP+KLA
 NM_011666 ubiquitin-like modifier activating enzyme 3 (Uba3), transcript variant 1, mRNA [NM_011666] KLA 1.18 1.10 1.18 .91 .93 .83 .96
ATP 1.12 1.10 1.22 .94 1.05 1.29 1.15
KLA/ATP 1.17 1.13 1.15 .83 .90 .98 1.10
Uba6
KLA  ATP  ATP+KLA
 AK017687 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730469D23 product:unclassifiable, full insert sequence [AK017687] KLA 1.65 1.57 1.98 1.64 1.49 1.24 1.04
ATP .99 1.06 1.03 .98 .88 1.13 .96
KLA/ATP 1.64 1.72 1.64 1.34 1.02 1.01 .90
Uba6
KLA  ATP  ATP+KLA
 NM_172712 ubiquitin-like modifier activating enzyme 6 (Uba6), mRNA [NM_172712] KLA 2.06 2.16 2.17 2.04 1.62 1.07 .96
ATP .98 1.09 1.14 1.03 .89 1.57 1.13
KLA/ATP 1.97 2.21 2.03 1.83 1.20 1.35 1.18
Ube1l
KLA  ATP  ATP+KLA
 NM_023738 ubiquitin-activating enzyme E1-like (Ube1l), mRNA [NM_023738] KLA 4.64 4.11 4.94 5.37 5.68 6.23 3.15
ATP .99 .85 1.04 .78 .57 2.63 2.71
KLA/ATP 4.18 3.71 4.72 3.27 3.28 5.59 6.15
Ube1y1
KLA  ATP  ATP+KLA
 NM_011667 ubiquitin-activating enzyme E1, Chr Y 1 (Ube1y1), mRNA [NM_011667] KLA 1.06 .99 .99 .97 1.00 1.05 1.00
ATP .99 .98 1.06 1.01 1.01 .99 1.02
KLA/ATP 1.06 1.04 1.03 .97 1.06 1.05 1.01
Ube2a
KLA  ATP  ATP+KLA
 NM_019668 ubiquitin-conjugating enzyme E2A, RAD6 homolog (S. cerevisiae) (Ube2a), mRNA [NM_019668] KLA 1.24 1.26 1.17 1.17 1.21 1.44 1.50
ATP 1.02 1.08 1.14 1.32 1.26 1.46 1.42
KLA/ATP 1.27 1.26 1.23 1.43 1.41 1.56 1.71
Ube2b
KLA  ATP  ATP+KLA
 AK135056 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430560N03 product:hypothetical protein, full insert sequence [AK135056] KLA .69 .59 .63 .66 .94 .88 .87
ATP .93 .81 .87 .82 1.35 .80 .81
KLA/ATP .59 .51 .62 .73 1.56 .83 1.07
Ube2b
KLA  ATP  ATP+KLA
 NM_009458 ubiquitin-conjugating enzyme E2B, RAD6 homology (S. cerevisiae) (Ube2b), mRNA [NM_009458] KLA .98 .95 1.02 .86 .93 1.00 1.01
ATP .98 .99 1.35 1.22 1.27 1.16 1.01
KLA/ATP .89 .94 1.21 1.04 1.27 1.25 1.21
Ube2c
KLA  ATP  ATP+KLA
 NM_026785 ubiquitin-conjugating enzyme E2C (Ube2c), mRNA [NM_026785] KLA .69 .72 .75 .57 .46 .26 .14
ATP .98 1.11 1.08 1.53 1.02 .53 .12
KLA/ATP .84 .74 .51 .88 .49 .25 .14
Ube2d1
KLA  ATP  ATP+KLA
 NM_145420 ubiquitin-conjugating enzyme E2D 1, UBC4/5 homolog (yeast) (Ube2d1), mRNA [NM_145420] KLA 1.74 2.10 2.22 1.61 1.21 1.02 1.06
ATP 1.17 1.45 .96 1.24 .68 .84 1.00
KLA/ATP 2.41 2.30 1.05 2.18 .84 1.02 1.32
Ube2d2
KLA  ATP  ATP+KLA
 NM_019912 ubiquitin-conjugating enzyme E2D 2 (Ube2d2), mRNA [NM_019912] KLA 1.29 1.29 1.41 1.23 1.36 1.30 1.31
ATP 1.07 1.17 1.00 1.15 1.11 1.28 1.04
KLA/ATP 1.38 1.39 .99 1.29 1.05 1.26 1.38
Ube2d3
KLA  ATP  ATP+KLA
 NM_025356 ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast) (Ube2d3), mRNA [NM_025356] KLA 1.72 1.77 1.76 1.74 1.73 1.55 1.38
ATP .98 1.14 1.06 1.22 1.45 1.85 1.13
KLA/ATP 1.64 1.62 1.41 1.80 1.60 1.97 1.74
Ube2e1
KLA  ATP  ATP+KLA
 NM_009455 ubiquitin-conjugating enzyme E2E 1, UBC4/5 homolog (yeast) (Ube2e1), mRNA [NM_009455] KLA 2.67 2.73 2.80 2.73 2.69 2.25 1.09
ATP .97 1.09 1.20 1.30 .97 .70 .67
KLA/ATP 2.41 2.82 2.81 3.36 2.55 1.99 .66
Ube2e2
KLA  ATP  ATP+KLA
 AK044807 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130003A05 product:unclassifiable, full insert sequence. [AK044807] KLA 2.38 2.04 2.04 1.47 1.69 1.32 1.21
ATP 1.29 1.95 3.29 2.85 3.11 1.82 .85
KLA/ATP 2.50 2.57 3.10 1.78 1.74 1.21 .91
Ube2e2
KLA  ATP  ATP+KLA
 NM_144839 ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) (Ube2e2), mRNA [NM_144839] KLA 2.97 2.73 2.87 3.45 2.77 1.98 1.24
ATP 1.04 .95 1.27 1.24 1.26 1.42 .68
KLA/ATP 2.64 3.10 3.67 3.17 3.00 1.50 .66
Ube2e3
KLA  ATP  ATP+KLA
 AK043446 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730096E21 product:unclassifiable, full insert sequence [AK043446] KLA .89 .98 .94 .95 .98 .97 1.04
ATP .96 .95 .98 .93 .97 .96 .92
KLA/ATP 1.01 .98 .90 .86 .81 .90 1.10
Ube2e3
KLA  ATP  ATP+KLA
 NM_009454 ubiquitin-conjugating enzyme E2E 3, UBC4/5 homolog (yeast) (Ube2e3), mRNA [NM_009454] KLA 1.04 .98 .94 .78 .67 .81 1.13
ATP .93 .92 1.02 1.04 .80 .66 .99
KLA/ATP 1.01 .92 .87 .91 .68 .57 .81
Ube2f
KLA  ATP  ATP+KLA
 AK030594 adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330436B09 product:NEDD8-conjugating enzyme NCE2 (EC 6.3.2.19) (Ubiquitin-conjugating enzyme E2) (Ubiquitin-protein ligase) (Ubiquitin carrier protein) homolog [Ho KLA 2.55 2.33 2.20 2.76 3.06 2.26 1.80
ATP .83 .77 1.04 1.02 1.59 1.35 .65
KLA/ATP 2.15 1.87 1.93 1.47 1.63 1.06 .70
Ube2f
KLA  ATP  ATP+KLA
 NM_026454 ubiquitin-conjugating enzyme E2F (putative) (Ube2f), mRNA [NM_026454] KLA 2.82 2.72 2.94 2.75 3.24 2.52 2.49
ATP 1.09 1.14 1.05 1.42 1.84 2.55 1.82
KLA/ATP 3.25 3.17 2.46 3.10 2.17 2.04 3.47
Ube2g1
KLA  ATP  ATP+KLA
 NM_025985 ubiquitin-conjugating enzyme E2G 1 (UBC7 homolog, C. elegans) (Ube2g1), mRNA [NM_025985] KLA 1.01 .97 .95 .79 .93 1.19 1.44
ATP 1.12 1.24 1.07 1.18 1.82 2.36 1.29
KLA/ATP 1.02 1.06 .80 1.06 1.59 2.40 1.85
Ube2g2
KLA  ATP  ATP+KLA
 NM_019803 ubiquitin-conjugating enzyme E2G 2 (Ube2g2), mRNA [NM_019803] KLA .67 .68 .71 .74 .88 1.15 1.22
ATP .99 1.06 1.06 1.16 1.56 1.24 1.08
KLA/ATP .67 .72 .78 .74 1.04 1.22 1.03
Ube2h
KLA  ATP  ATP+KLA
 AK039198 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230106O05 product:ubiquitin-conjugating enzyme E2H, full insert sequence [AK039198] KLA .72 .78 .77 .57 .70 .68 .71
ATP 1.07 1.16 1.00 1.45 1.52 .62 .47
KLA/ATP .90 .87 .64 .95 1.25 .88 .33
Ube2h
KLA  ATP  ATP+KLA
 NM_009459 ubiquitin-conjugating enzyme E2H (Ube2h), mRNA [NM_009459] KLA 1.44 1.42 1.36 1.26 1.31 1.33 1.26
ATP 1.06 1.21 1.06 1.47 1.47 1.50 1.53
KLA/ATP 1.61 1.65 1.25 1.67 1.51 1.65 2.61
Ube2i
KLA  ATP  ATP+KLA
 BC037635 ubiquitin-conjugating enzyme E2I, mRNA (cDNA clone MGC:46871 IMAGE:4951933), complete cds. [BC037635] KLA .79 .80 .78 .82 .95 .90 .98
ATP .96 1.00 .77 .96 1.41 1.01 1.00
KLA/ATP .80 .83 .68 .89 1.03 .93 .79
Ube2i
KLA  ATP  ATP+KLA
 NM_011665 ubiquitin-conjugating enzyme E2I (Ube2i), mRNA [NM_011665] KLA .75 .76 .74 .71 .70 .63 .78
ATP 1.03 1.02 .95 1.02 .93 .66 .75
KLA/ATP .81 .80 .71 .80 .75 .60 .61
Ube2j1
KLA  ATP  ATP+KLA
 NM_019586 ubiquitin-conjugating enzyme E2, J1 (Ube2j1), mRNA [NM_019586] KLA 1.36 1.31 1.41 1.35 1.28 1.42 1.42
ATP 1.09 1.11 1.15 1.19 1.63 2.57 1.53
KLA/ATP 1.41 1.44 1.43 1.42 1.59 2.08 1.94
Ube2j2
KLA  ATP  ATP+KLA
 NM_021402 ubiquitin-conjugating enzyme E2, J2 homolog (yeast) (Ube2j2), transcript variant 1, mRNA [NM_021402] KLA 1.20 1.08 1.25 1.17 1.28 1.25 1.56
ATP 1.11 1.09 .97 1.17 1.45 1.67 1.49
KLA/ATP 1.22 1.16 1.00 .97 1.18 1.63 1.68
Ube2k
KLA  ATP  ATP+KLA
 NM_016786 ubiquitin-conjugating enzyme E2K (UBC1 homolog, yeast) (Ube2k), mRNA [NM_016786] KLA 1.11 1.10 1.07 1.10 .98 1.10 1.19
ATP .96 .96 1.09 1.04 1.17 1.45 1.08
KLA/ATP 1.06 1.06 1.20 1.07 1.25 1.18 1.00
Ube2l3
KLA  ATP  ATP+KLA
 NM_009456 ubiquitin-conjugating enzyme E2L 3 (Ube2l3), mRNA [NM_009456] KLA 1.21 1.14 1.23 1.35 1.35 1.56 1.41
ATP .99 1.18 1.11 1.42 1.37 1.45 1.83
KLA/ATP 1.26 1.34 1.32 1.77 1.56 1.80 2.39
Ube2l6
KLA  ATP  ATP+KLA
 NM_019949 ubiquitin-conjugating enzyme E2L 6 (Ube2l6), mRNA [NM_019949] KLA 2.11 2.33 2.47 1.97 2.66 3.13 3.86
ATP 1.11 1.30 1.06 1.42 1.10 1.30 2.96
KLA/ATP 2.40 2.29 1.58 2.86 2.10 3.13 5.78
Ube2m
KLA  ATP  ATP+KLA
 NM_145578 ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast) (Ube2m), mRNA [NM_145578] KLA 1.35 1.55 1.54 1.47 1.72 1.77 1.75
ATP 1.13 1.26 .87 1.35 1.15 1.15 1.31
KLA/ATP 1.70 1.50 1.01 1.91 1.27 1.91 3.22
Ube2n
KLA  ATP  ATP+KLA
 NM_080560 ubiquitin-conjugating enzyme E2N (Ube2n), mRNA [NM_080560] KLA 1.52 1.48 1.47 1.43 1.42 1.42 1.37
ATP 1.01 1.14 1.23 1.40 1.01 1.15 1.33
KLA/ATP 1.48 1.56 1.40 1.84 1.21 1.23 1.43
Ube2o
KLA  ATP  ATP+KLA
 NM_173755 ubiquitin-conjugating enzyme E2O (Ube2o), mRNA [NM_173755] KLA .82 .74 .63 .71 .69 .77 1.11
ATP .94 .96 1.04 1.04 1.45 1.75 1.13
KLA/ATP .77 .81 .82 .86 1.21 1.39 1.02
Ube2q1
KLA  ATP  ATP+KLA
 NM_027315 ubiquitin-conjugating enzyme E2Q (putative) 1 (Ube2q1), mRNA [NM_027315] KLA .85 .85 .99 1.07 1.28 1.48 1.23
ATP 1.03 1.00 1.08 1.31 1.01 1.06 1.14
KLA/ATP .87 .87 .88 1.12 1.53 1.57 1.23
Ube2q2
KLA  ATP  ATP+KLA
 NM_180600 ubiquitin-conjugating enzyme E2Q (putative) 2 (Ube2q2), mRNA [NM_180600] KLA 1.19 1.13 1.11 1.15 1.27 1.29 1.79
ATP 1.13 1.13 1.01 1.11 1.29 1.67 1.48
KLA/ATP 1.17 1.16 1.04 1.05 1.00 1.03 1.70
Ube2r2
KLA  ATP  ATP+KLA
 NM_026275 ubiquitin-conjugating enzyme E2R 2 (Ube2r2), mRNA [NM_026275] KLA 1.39 1.46 1.60 1.66 1.81 1.67 1.31
ATP 1.06 1.08 1.05 1.12 1.30 1.61 1.07
KLA/ATP 1.47 1.54 1.47 1.67 1.96 2.09 1.55
Ube2s
KLA  ATP  ATP+KLA
 AK003078 adult male spleen cDNA, RIKEN full-length enriched library, clone:0910001J09 product:ubiquitin carrier protein E2 homolog [Homo sapiens], full insert sequence. [AK003078] KLA 1.26 1.39 1.67 1.40 1.50 1.31 .82
ATP 1.08 1.13 1.21 1.24 1.29 1.38 .73
KLA/ATP 1.47 1.43 1.70 1.74 1.68 1.43 1.09
Ube2s
KLA  ATP  ATP+KLA
 NM_133777 ubiquitin-conjugating enzyme E2S (Ube2s), mRNA [NM_133777] KLA 1.27 1.37 1.56 1.40 1.41 1.21 .85
ATP .97 1.03 1.16 1.25 1.30 1.42 .71
KLA/ATP 1.32 1.40 1.51 1.54 1.59 1.52 1.04
Ube2u
KLA  ATP  ATP+KLA
 NM_001033773 ubiquitin-conjugating enzyme E2U (putative) (Ube2u), mRNA [NM_001033773] KLA .98 .96 1.06 .94 1.03 .98 .94
ATP .94 1.03 1.02 .97 1.02 1.03 1.04
KLA/ATP 1.01 1.09 1.00 1.00 1.03 .97 1.00
Ube2w
KLA  ATP  ATP+KLA
 AK053599 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130112P14 product:unclassifiable, full insert sequence [AK053599] KLA .98 .83 .89 .95 .97 .92 .94
ATP .93 .89 .81 .87 .93 .91 .94
KLA/ATP .84 .81 .86 .85 .92 .88 .90
Ube2w
KLA  ATP  ATP+KLA
 NM_025773 ubiquitin-conjugating enzyme E2W (putative) (Ube2w), mRNA [NM_025773] KLA 1.36 1.34 1.37 1.39 1.46 1.29 .92
ATP 1.06 .99 1.24 .94 .99 1.19 .88
KLA/ATP 1.30 1.39 1.49 1.15 1.06 1.03 .86
Ube2z
KLA  ATP  ATP+KLA
 NM_172300 ubiquitin-conjugating enzyme E2Z (putative) (Ube2z), mRNA [NM_172300] KLA 1.53 1.52 1.77 1.82 2.09 1.56 1.32
ATP 1.09 1.16 .90 .95 1.48 1.72 1.02
KLA/ATP 1.70 1.73 1.30 1.57 1.67 1.93 1.60
Ube3a
KLA  ATP  ATP+KLA
 NM_011668 ubiquitin protein ligase E3A (Ube3a), transcript variant 2, mRNA [NM_011668] KLA 1.28 1.18 1.12 1.18 1.07 1.04 1.08
ATP .83 .60 .51 .30 .70 1.18 1.04
KLA/ATP 1.05 .82 .75 .42 .88 1.07 .93
Ube3a
KLA  ATP  ATP+KLA
 NM_173010 ubiquitin protein ligase E3A (Ube3a), transcript variant 1, mRNA [NM_173010] KLA 1.06 1.02 .95 .94 .96 .91 1.07
ATP .85 .63 .39 .27 .64 .83 .93
KLA/ATP .96 .72 .47 .32 .66 .78 .84
Ube3b
KLA  ATP  ATP+KLA
 NM_054093 ubiquitin protein ligase E3B (Ube3b), mRNA [NM_054093] KLA .81 .81 .83 .70 .70 .61 .66
ATP 1.03 1.01 .79 .75 .68 .54 .67
KLA/ATP .88 .84 .52 .55 .51 .55 .70
Ube3c
KLA  ATP  ATP+KLA
 NM_133907 ubiquitin protein ligase E3C (Ube3c), mRNA [NM_133907] KLA 1.03 1.04 .91 .84 .77 .79 1.07
ATP 1.06 .99 1.00 .75 .65 1.00 .96
KLA/ATP 1.14 1.00 .75 .68 .58 .82 .69
Ube4a
KLA  ATP  ATP+KLA
 ENSMUST00000034604 ens|ubiquitination factor E4A [Source:RefSeq_peptide;Acc:NP_663375] [ENSMUST00000034604] KLA 1.08 1.05 1.06 1.06 1.15 1.12 1.24
ATP 1.03 1.00 .99 .87 1.31 2.25 1.66
KLA/ATP 1.16 1.08 .99 .90 1.25 2.12 1.64
Ube4a
KLA  ATP  ATP+KLA
 NM_145400 ubiquitination factor E4A, UFD2 homolog (S. cerevisiae) (Ube4a), mRNA [NM_145400] KLA 1.07 1.24 1.19 1.06 1.23 1.98 1.69
ATP 1.09 1.26 .83 .52 .78 1.66 1.22
KLA/ATP 1.13 1.28 .96 .80 .99 1.63 2.16
Ube4b
KLA  ATP  ATP+KLA
 NM_022022 ubiquitination factor E4B, UFD2 homolog (S. cerevisiae) (Ube4b), mRNA [NM_022022] KLA 1.41 1.36 1.28 .90 .78 .88 1.12
ATP 1.09 1.17 .96 1.08 1.14 1.41 .97
KLA/ATP 1.55 1.45 .98 .90 .80 1.40 1.24
Ubox5
KLA  ATP  ATP+KLA
 NM_080562 U box domain containing 5 (Ubox5), mRNA [NM_080562] KLA 1.20 1.18 1.10 1.02 1.19 1.29 1.21
ATP 1.03 .99 .75 .50 .71 1.08 1.27
KLA/ATP 1.24 1.09 .83 .73 .98 1.24 1.23
Ubr5
KLA  ATP  ATP+KLA
 NM_001081359 ubiquitin protein ligase E3 component n-recognin 5 (Ubr5), transcript variant 1, mRNA [NM_001081359] KLA 1.09 1.10 1.00 .95 1.07 .98 1.14
ATP 1.05 1.08 .81 1.23 .92 .85 .92
KLA/ATP 1.15 1.14 .74 1.03 .81 .79 .92
Vhlh
KLA  ATP  ATP+KLA
 S76748 gb|mVHLh1=von Hippel-Lindau disease gene [mice, mRNA, 2757 nt]. [S76748] KLA 1.39 1.39 1.47 1.46 1.62 1.84 1.48
ATP .73 .64 .54 .55 1.44 2.26 1.44
KLA/ATP 1.17 1.13 .91 .73 1.72 2.26 2.16
Wwp1
KLA  ATP  ATP+KLA
 NM_177327 WW domain containing E3 ubiquitin protein ligase 1 (Wwp1), mRNA [NM_177327] KLA .55 .52 .40 .36 .26 .24 .40
ATP 1.03 1.13 .87 .82 .51 .25 .68
KLA/ATP .54 .52 .35 .40 .29 .21 .31
Wwp2
KLA  ATP  ATP+KLA
 NM_025830 WW domain containing E3 ubiquitin protein ligase 2 (Wwp2), mRNA [NM_025830] KLA .91 .90 .90 .89 .98 1.17 1.13
ATP 1.02 1.03 1.04 .95 .92 1.15 1.62
KLA/ATP .90 .91 .91 .85 .87 1.18 1.79
Xiap
KLA  ATP  ATP+KLA
 NM_009688 X-linked inhibitor of apoptosis (Xiap), mRNA [NM_009688] KLA 1.61 1.63 1.62 1.52 1.34 1.27 1.11
ATP 1.03 1.01 .99 .96 .88 1.19 1.25
KLA/ATP 1.64 1.63 1.54 1.33 1.08 1.19 1.72